ARCHIVES

IVAX And It’s Portfolio

This article is from The Cancer Letter archive.

Vol. 20 No. 49 | December 22, 1994

Download PDF Visit The Full Archive

Related Articles

Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing

November 1, 2012

NY Federal Court Rules Against Myriad, Finding Patents On Genes Unlawful.

April 2, 2010

“Whatever Happened To…?” ACS Follows Up Five Years Later

August 26, 1977

Pastan’s Laboratory Creates “Chimeric” Monoclonal Antibody With Human, Muse

August 12, 1988

Stop Cancer Promises $7 Mil. By End Of Year

October 12, 1990

Abstract Of Papers From ACTR Meeting

October 22, 1976